Skip to the main content.

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

Tom French : 28 July 2025

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

This article traces the evolution of API-in-capsule (AIC) technology, from its early disruption of traditional formulation through the Xcelodose® system, to its reinvention in 3P innovation’s Fill2Weight platform. The authors explore how AIC has shifted from a risky bet to a scalable solution for modern drug development. Looking ahead, they highlight the transformative role AIC can play in personalised medicine, oncology, and DPI, where flexibility and precision are key to success.

Authors:

  • Tom French (Head of Process Technology- 3P innovation)
  • Dave Miller (CSO- AustinPx)
  • Derek Hennecke (CEO- Grand River Aseptic Manufacturing)

READ THE WHITEPAPER HERE
Behind the scenes of 3P innovation's Customer Care team

Behind the scenes of 3P innovation's Customer Care team

Picture of Georgia Lewis-Marston Georgia Lewis-Marston: 17 October 2025

This week, I had the chance to sit down with Paul Beard, Operations Director at 3P innovation, to explore what truly distinguishes our Customer Care...

Read More
Filling syringes with spray-dried powders - the how, the why and the benefits.

Filling syringes with spray-dried powders - the how, the why and the benefits.

David Phasey: 15 October 2025

For many therapy developers, the challenge doesn’t start in manufacturing, it begins much earlier in formulation. Once a promising therapy has...

Read More
What does Annex 1 mean for cryovial filling? Insights from 3P innovation.

What does Annex 1 mean for cryovial filling? Insights from 3P innovation.

Charles Pilato: 6 October 2025

The revision of EU GMP Annex 1 has redefined expectations for sterile manufacturing across the life sciences sector and nowhere is this felt more...

Read More